Delivery Order SPE2DB22D2211-SPE2DB24FNBB6
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical distributor. The $1,979.10 order is for the supply of Cefazolin 2 g/50 mL-dextroses, a specialty pharmaceutical product, in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.75 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML in dextrose solution. The contract employs firm fixed price terms and is scheduled for ultimate completion on July 30, 2025, just one day after the award date of July 29, 2025. This delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $2,167.92, is for the supply of 4,564,083,639 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- The Defense Logistics Agency awarded a $2,850.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by November 14, 2025. This non-competitive delivery order represents a discrete purchase under AmerisourceBergen's larger contract vehicle with DLA and reflects the company's role as a critical supplier of pharmaceutical products to federal military and healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solution, valued at $1,228.56, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50mL with dextrose, an antibiotic pharmaceutical product. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cefazolin 2 g/50 ml-dextrose pharmaceutical products. The delivery order, valued at $2,381.22, has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) the company holds with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,550 units of the pharmaceutical product Cefazolin 2 g/50 mL-Dextroses. The contract, valued at $7,257.47, has an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product, with a potential value of $2,890.56. The delivery order has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is a for-profit prime contractor that holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNBB6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation located in Conshohocken, Pennsylvania. The $1,024.86 order is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current delivery order was issued under this larger IDC, which does not have any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/22/24 |